Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC114/rtv Monotherapy in Treatment-Naïve HIV-1
NCT00513513Phase 2Terminated
- Sponsor
- Tibotec
- Start
- Sep 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Sep 2006; status: terminated.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00513513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513513.